Sherwin-Williams 2Q Profit Tops Estimates Despite Choppy Demand Environment
By Denny Jacob
Sherwin-Williams posted better-than-expected profit in its latest quarter despite facing ongoing choppiness in the overall demand environment.
The paint and coatings company logged net income of $889.9 million, or $3.50 a share, for the second quarter ended June 30, up from $793.7 million, or $3.07 a share, a year earlier. Adjusted earnings were $3.70 a share, above analysts' estimates of $3.49 a share.
Sales ticked up to $6.27 billion from $6.24 billion. Analysts polled by FactSet expected $6.33 billion.
Paint Store Group sales increased primarily due to low-single digit sales volume growth and ongoing realization of higher selling prices set in place earlier in the year. Consumer Brands Group sales decline due in part to a mid-single digit percentage sales volume decline as a result of soft do-it-yourself demand in North America, among other factors.
Sherwin-Williams forecast sales to be up by a low-single digit percentage in the third quarter.
For full year 2024, the company now sees sales up by a low-single digit percentage rather than up low to mid-single digit percentage as it guided for in April. The company said the change reflected continued demand uncertainty in several end markets. It raised its adjusted earnings per-share outlook to between $11.10 and $11.40 compared to its prior guidance in the range of $10.85 a share and $11.35 a share.
Write to Denny Jacob at denny.jacob@wsj.com
(END) Dow Jones Newswires
July 23, 2024 07:39 ET (11:39 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
What’s the Difference Between the CPI and PCE Indexes?
-
Micron Earnings: Great Guidance but Stock Now Looks Fairly Valued
-
August PCE Report Forecasts Show More Good News on Inflation
-
AI Stocks May Be Down, but Don’t Count Them Out
-
4 Stocks to Buy as the Fed Cuts Interest Rates
-
Markets Brief: The Uncertain Path to Neutral Interest Rates
-
What’s Happening in the Markets This Week
-
Where Top Stock Fund Managers Are Looking Next After the Fed Rate Cut
-
Our Top Pick for Investing in US Renewable Energy
-
How to Measure a Stock’s Uncertainty
-
How to Determine Whether a Stock Is Cheap, Expensive, or Fairly Valued
-
Why a Company’s Management and Capital Allocation Matter
-
How to Determine What a Stock Is Worth
-
How to Measure a Company’s Competitive Advantage
-
How to Think Like a Stock Analyst
-
How GLP-1 Drugs Like Ozempic Are Boosting Biopharma Stocks